Filing Details

Accession Number:
0001562180-24-006776
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-09-11 18:00:22
Reporting Period:
2024-09-09
Accepted Time:
2024-09-11 18:00:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1831363 Terns Pharmaceuticals Inc. TERN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1799780 M. Jill Quigley C/O Terns Pharmaceuticals, Inc.
1065 East Hillsdale Blvd., Suite 100
Foster City CA 94404
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-09-09 17,235 $1.82 32,235 No 4 M Direct
Common Stock Disposition 2024-09-09 17,235 $10.00 15,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-09-09 17,235 $0.00 17,235 $1.82
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2023-06-12 2032-06-15 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2024.
  2. The option vested in full immediately prior to the Annual Meeting following the date of grant.